5 Best Low Priced Biotech Stocks to Invest In

3. Relay Therapeutics, Inc. (NASDAQ:RLAY)

Relay Therapeutics, Inc. (NASDAQ:RLAY) is one of the best low priced biotech stocks to invest in. On April 13, JonesResearch initiated coverage of Relay Therapeutics, Inc. (NASDAQ:RLAY) with a Hold rating and $18 price target. The firm stated that it has a bullish outlook for the company’s pipeline and zovegalisib’s prospects, and cited valuation for the Hold rating following the stock’s recent strength.

For additional perspective, Relay Therapeutics, Inc. (NASDAQ:RLAY) announced in its fiscal Q4 and full year 2025 results that as of December 31, 2025, its cash, cash equivalents, and investments totaled $554.5 million, compared to approximately $781.3 million as of December 31, 2024. The company anticipates its current cash, cash equivalents, and investments to be sufficient to fund its operating expenses and capital expenditure requirements into 2029. Relay Therapeutics, Inc. (NASDAQ:RLAY) also reported that revenue for fiscal Q4 2025 came up to $7.0 million, compared to $0 for the fourth quarter of 2024. Revenue for the full year 2025 was $15.4 million, compared to $10.0 million for the full year 2024.

Relay Therapeutics, Inc. (NASDAQ:RLAY) is a clinical-stage precision medicine company that uses advanced computational and experimental technologies to innovate drug discovery. Its primary focus is on genetic disease indications and targeted oncology. The company’s Dynamo platform integrates a range of cutting-edge experimental and computational approaches to understand protein structure and motion in drug discovery.